Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions Review

sustainable development goals

publication date

  • May 18, 2020

webpage

published in

keywords

  • IL-17
  • Psoriasis
  • brodalumab
  • herpes zoster
  • ixekizumab
  • secukinumab
  • varicella zoster

start page

  • 359

end page

  • 365

volume

  • 31

issue

  • 4